CN Patent
CN113117376B — 一种邻菲罗啉衍生的萃取剂及其制法和应用
Assigned to Institute of High Energy Physics of CAS · Expires 2022-08-19 · 4y expired
What this patent protects
本发明提供了一种邻菲罗啉衍生的萃取剂及其制备方法和应用,该萃取剂的结构式如下: 本发明的萃取剂合成简单,萃取动力学快(10min达到萃取平衡),镧锕分离效果好,仅含有C、H、O、N四种元素,焚烧时不产生二次放射性固体污染,因而在乏燃料后处理中镧锕分离方向具有广阔的应用前景。
USPTO Abstract
本发明提供了一种邻菲罗啉衍生的萃取剂及其制备方法和应用,该萃取剂的结构式如下: 本发明的萃取剂合成简单,萃取动力学快(10min达到萃取平衡),镧锕分离效果好,仅含有C、H、O、N四种元素,焚烧时不产生二次放射性固体污染,因而在乏燃料后处理中镧锕分离方向具有广阔的应用前景。
Drugs covered by this patent
- Klisyri (TIRBANIBULIN) · Almirall
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.